Awards & Advancement

Lophius Biosciences expands management team

Friday, July 15, 2011 10:32 AM

Lophius Biosciences, a developer of T-cell-based diagnostic test systems, has expanded its management team.

More... »

InSite Vision raises $22.2 million

Thursday, July 14, 2011 12:28 PM

InSite Vision has entered into a private placement financing transaction of approximately $22.2 million in exchange for the issuance of approximately 37 million shares of InSite Vision common stock and warrants to purchase approximately 14.8 million shares of InSite Vision common stock.

More... »

ADDF, Charles River collaborate in research award program

Wednesday, July 13, 2011 10:27 AM

The Alzheimer's Drug Discovery Foundation (ADDF) is collaborating with Charles River Laboratories International, a provider of early-stage drug development products and services, to create a new research award program entitled Use of Aged Rats as a Relevant Pre-clinical Model for the Development of Therapies for Cognitive Aging and Alzheimer's Disease.  The program is made possible through a donation from Charles River's Discovery Services business and funds from the ADDF.

More... »

BD Biosciences names research grant recipients

Wednesday, July 13, 2011 10:25 AM

Biosciences, a segment of BD (Becton, Dickinson and Company), has announced the spring 2011 winners of its Research Grant Program.

More... »

Delta Point names Murphy executive account director

Wednesday, July 13, 2011 10:23 AM

Delta Point has named Matt Murphy executive account director.

More... »

Ignite Health names Lefkowitz chief creative officer

Wednesday, July 13, 2011 10:19 AM

Ignite Health, an inVentiv Health company, has named Brian Lefkowitz its chief creative officer. Lefkowitz will be responsible for leading all creative efforts as well as building a unified creative structure for the agency's East and West coast offices.

More... »

Hutchinson Center to lead $20 million HIV research grant

Tuesday, July 12, 2011 12:25 PM

Whether a stem cell transplant using an HIV-infected person’s own genetically modified immune cells can become a cure for the disease is the focus of a new $20 million, five-year research grant award announced by the National Institutes of Health to the Fred Hutchinson Cancer Research Center.

More... »

Avila names Hirsch CFO

Tuesday, July 12, 2011 10:14 AM

Avila Therapeutics, a biotechnology company developing targeted covalent drugs, has named Andrew Hirsch its first chief financial officer.

More... »

Vycor names head of strategic advisory board

Monday, July 11, 2011 12:51 PM

Vycor Medical has named Alvaro Pascual-Leone, M.D., Ph.D., head of the strategic advisory board of its NovaVision subsidiary.

More... »

Sangamo names Nichol executive vice president of R&D

Monday, July 11, 2011 12:48 PM

Sangamo BioSciences has named Geoffrey M. Nichol executive vice president, R&D. In this newly created position, Dr. Nichol will oversee all of the company's research and clinical development activities and operations.

More... »